Kaiqui Wu

1 Introduction Breast cancer is the most common cancer type in women and accounts for 36% of cancer patients worldwide. In 2018 about 2.089 million women were diagnosed with breast cancer.[1] Particularly problematic are triple negative breast cancer (TNBC) since it has the poorest outcome prognosis and lacks targeted treatment options among all breast cancer subtypes.[2] TNBC accounts for ≈15–20% of breast cancers.